Intelligence Platform

Patents

Browse 259 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8474529

Control of concentric tubing direction

Regency Technologies LLC · Granted Tue Jul 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8470312

Abrogating proinflammatory cytokine production during oncolytic reovirus therapy

ONCOLYTICS BIOTECH INC. · Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8470364

Once daily formulations of tetracyclines

Supernus Pharmaceuticals, Inc. · Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8461339

Pharmaceutical compounds

SENTINEL ONCOLOGY LIMITED · Granted Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8449911

Drug composition having active ingredient adhered at high concentration to spherical core

Takeda Pharmaceutical Company Limited · Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8445541

Methods for concomitant administration of colchicine and a second active agent

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8440722

Methods for concomitant administration of colchicine and a second active agent

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8440721

Methods for concomitant administration of colchicine and a second active agent

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8394406

Once daily formulations of tetracyclines

Supernus Pharmaceuticals, Inc. · Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8394405

Once daily formulations of tetracyclines

Supernus Pharmaceuticals, Inc. · Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8372848

Melanin-concentrating hormone receptor antagonists and methods of use

The Regents of the University of California · Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8372872

Methods for concomitant treatment of theophylline and febuxostat

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8357379

High concentration baclofen preparations

The Board of Regents of the University of Texas System · Granted Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8323634

Stable formulations of highly concentrated recombinant human albumin-human granulocyte col

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8206740

Once daily formulations of tetracyclines

Supernus Pharmaceuticals, Inc. · Granted Tue Jun 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8147845

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8080241

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8071087

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8066985

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8062647

High concentration baclofen preparations

The Board of Regents of the University of Texas System · Granted Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8008038

Methods for determining oxygen concentration with protoporphyrin IX

ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964186

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964187

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

ONCOLYTICS BIOTECH INC. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7906535

High concentration topical insecticides containing pyrethroids

Summit VetPharm, LLC · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted